Article

Glistening-free, hydrophobic acrylic IOL debuts

A new glistening-free, hydrophobic acrylic IOL (enVista, Bausch + Lomb) debuted at the annual meeting of the European Society of Cataract and Refractive Surgeons here.

Vienna, Austria-A new glistening-free, hydrophobic acrylic IOL (enVista, Bausch + Lomb) debuted at the annual meeting of the European Society of Cataract and Refractive Surgeons here.

The lens’ aspheric, aberration-free technology (Advanced Optics, Bausch + Lomb) is designed to deliver enhanced contrast sensitivity and better vision quality, and its 360° square-edge barrier design aims to provide an effective optic-haptic junction to minimize posterior capsular opacification.

“We are proud to innovate the hydrophobic lens category with an IOL that provides a high quality of vision and addresses the common issue of glistenings,” said Robert Grant, chief executive officer and president of global surgical business for Bausch + Lomb. “It was important that we deliver an advanced hydrophobic lens that surgeons and patients can count on now and over the long term, and data [show] that we have achieved that.”

The hydrophobic lens has received CE mark approval in the European Union. Additional approvals are pending worldwide, according to the company.

For more articles in this issue of

Ophthalmology Times Conference Brief

click here

.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.